Notes · Forensic Medicine · 14 November 2026

Sudden cardiac death in young athletes – forensic perspective

Definition

• Sudden cardiac death (SCD) in young athletes is an unexpected natural death due to cardiac causes that occurs within one hour of the onset of symptoms, or is discovered unwitnessed within 24 h of the last time the person was seen alive and well, in individuals usually aged ≤35 years who are engaged in regular competitive or high‑intensity sports.

Epidemiology

• The overall incidence of SCD in athletes ranges from 0.5 to 2 per 100 000 athlete‑years, but rates are higher in males (≈ 70 % of cases) and in sports with high static or dynamic components such as basketball, soccer, and American football.
• Autopsy‑based studies in the United States and Europe report that ≈ 80 % of SCDs in athletes are due to structural heart disease, while ≈ 20 % are caused by primary electrical disorders.
• The risk is greatest in the first few years after initiating intense training, and in athletes of African descent where hypertrophic cardiomyopathy (HCM) and anomalous coronary arteries are relatively more common.

Aetiology (Forensic Perspective)

• Hypertrophic cardiomyopathy (HCM): Most frequent cause; asymmetric septal hypertrophy > 15 mm with myocyte disarray.
• Congenital coronary artery anomalies (CAA): Aberrant origin of a coronary artery from the opposite sinus, especially an inter‑arterial course between aorta and pulmonary trunk, leading to compression during exertion.
• Arrhythmogenic right ventricular cardiomyopathy (ARVC): Fibrofatty replacement of right ventricular myocardium causing ventricular arrhythmias.
• Myocarditis: Often viral; inflammatory infiltrates and myocyte necrosis predispose to lethal arrhythmias.
• Long QT syndrome (LQTS) and other channelopathies: Genetic defects in cardiac ion channels causing prolonged repolarisation and torsades de pointes.
• Commotio cordis: Non‑penetrating blunt chest trauma (e.g., baseball or hockey puck) causing ventricular fibrillation without structural damage.
• Aortic dissection or rupture: Rare in young athletes but can occur in connective‑tissue disorders (Marfan syndrome).
• Substance‑related causes: Stimulants (e.g., cocaine, ephedrine) or performance‑enhancing drugs can precipitate arrhythmias.

Pathophysiology

• Structural substrates (HCM, CAA, ARVC) create areas of abnormal conduction or mechanical obstruction, leading to ventricular tachyarrhythmias during the catecholamine surge of intense exercise.
• Ischaemic mechanisms in CAA arise from dynamic compression of the anomalous artery, reducing coronary flow precisely when myocardial oxygen demand peaks.
• Inflammatory injury in myocarditis disrupts gap junctions and creates re‑entry circuits, facilitating ventricular fibrillation.
• Channelopathies alter the balance of inward and outward ionic currents, prolonging the QT interval or shortening the refractory period, which predisposes to polymorphic ventricular tachycardia.
• Commotio cordis produces a sudden rise in intrathoracic pressure that mechanically stimulates the ventricular myocardium at a vulnerable phase of the cardiac cycle (the upstroke of the T wave), triggering ventricular fibrillation.

Clinical Features (Ante‑mortem)

• Most SCDs are unwitnessed; when witnessed, the collapse is abrupt, often preceded by a brief prodrome of chest discomfort, palpitations, or syncope.
• The athlete typically becomes unresponsive within seconds, with no palpable pulse and agonal breathing.
• Immediate bystander CPR and defibrillation are the only interventions that can restore circulation; without them, death occurs within 5–10 min.

Investigations (Forensic)

Antemortem (if the athlete survives the event)

• 12‑lead electrocardiogram (ECG): May reveal pathological Q‑waves (prior infarction), ST‑segment changes, prolonged QT, or ventricular pre‑excitation.
• Echocardiography: First‑line imaging to assess wall thickness, outflow tract obstruction, ventricular function, and coronary origins.
• Cardiac magnetic resonance (CMR): Provides detailed tissue characterization (fibrosis, fatty infiltration) and is superior for diagnosing ARVC and myocarditis.
• Exercise stress testing: Identifies exercise‑induced arrhythmias or abnormal blood pressure response.

Post‑mortem (medico‑legal autopsy)

• External examination: Look for traumatic injuries, drug paraphernalia, or signs of systemic disease (e.g., Marfanoid habitus).
• Cardiovascular dissection: Measure ventricular wall thickness, assess coronary artery origins, and examine for myocardial fibrosis or fatty infiltration.
• Histopathology: Stain sections with haematoxylin‑eosin and Masson’s trichrome to identify myocyte disarray (HCM), inflammatory infiltrates (myocarditis), or fibrofatty replacement (ARVC).
• Toxicology: Screen blood, urine, and vitreous humor for stimulants, anabolic steroids, or illicit drugs that could precipitate arrhythmia.
• Molecular autopsy: Perform next‑generation sequencing on DNA extracted from tissue to detect pathogenic variants in genes associated with channelopathies (e.g., KCNQ1, SCN5A).

Management (Prevention & Acute Response)

Screening Guidelines (2024)

• American Heart Association (AHA) 2024 recommendation: A tiered screening program for competitive athletes that includes a focused personal and family history, a physical examination, and a 12‑lead ECG for all athletes ≥ 14 years.
• European Society of Cardiology (ESC) 2023 recommendation: Mandatory ECG for all elite athletes, with interpretation using the “International Criteria” to reduce false‑positive rates.

Pre‑participation Evaluation (PPE)

• Obtain a detailed family history of SCD, unexplained syncope, or known cardiac disease.
• Conduct a physical exam focusing on blood pressure, cardiac murmurs, and dysmorphic features suggestive of connective‑tissue disorders.
• Perform a resting ECG; abnormal findings (e.g., pathological Q‑waves, T‑wave inversion beyond V2, QTc > 460 ms in males) mandate further cardiology referral.

Risk‑reduction Strategies

• Restriction from high‑intensity sport for athletes diagnosed with HCM, ARVC, significant CAA, or uncontrolled channelopathy.
• Beta‑blockers for LQTS or catecholaminergic polymorphic ventricular tachycardia (CPVT) as per 2023 ESC guidelines.
• Implantable cardioverter‑defibrillator (ICD): Indicated in survivors of cardiac arrest, sustained ventricular tachycardia, or HCM with massive hypertrophy (> 30 mm) and family history of SCD.

Emergency Action Plan (EAP)

• Every training venue must have an automated external defibrillator (AED) accessible within 3 minutes of collapse.
• Bystander CPR should be initiated immediately; chest compressions at a rate of 100‑120 compressions per minute and depth of 5‑6 cm.
• Defibrillation should be delivered as soon as the AED advises shock; each shock is followed by immediate resumption of CPR for 2 minutes.

Complications (Forensic and Legal)

• Misclassification of death: Failure to perform a thorough autopsy can lead to under‑reporting of inherited cardiac disease, affecting family screening.
• Liability issues: Institutions that lack an AED or an EAP may face negligence claims if an athlete dies from SCD.
• Psychological impact: Sudden loss of a teammate can cause acute stress reactions and long‑term mental health problems among peers and coaches.

High‑Yield Exam Points

• Definition: SCD = unexpected natural death from cardiac cause within 1 hour of symptom onset in a young athlete.
• Most common structural cause: Hypertrophic cardiomyopathy (≈ 35‑40 % of cases).
• Key congenital anomaly: Anomalous origin of the left coronary artery from the right sinus with an inter‑arterial course.
• Forensic hallmark of HCM: Asymmetric septal hypertrophy > 15 mm with myocyte disarray on histology.
• Commotio cordis: Requires a direct blow to the precordium at a vulnerable phase of the cardiac cycle; no structural damage is seen on autopsy.
• Screening recommendation (2024 AHA): History, physical exam, and resting ECG for all competitive athletes ≥ 14 years.
• Immediate management: CPR + AED within 3 minutes; each shock followed by 2 minutes of CPR.
• Molecular autopsy: Essential when routine autopsy is inconclusive; identifies channelopathy‑related gene mutations.
• Legal duty: Sports organizations must provide AEDs and trained personnel; failure can be deemed negligent.

Practice questions

1. Which of the following is the single most common structural cardiac abnormality identified on autopsy as the cause of sudden cardiac death in young athletes?
   Answer: Hypertrophic cardiomyopathy — it accounts for about one‑third of autopsy‑proven cases.

2. A 17‑year‑old male collapses during a basketball game after being struck in the chest by a ball. Immediate CPR is started, and the AED advises a shock. The most likely forensic diagnosis is:
   Answer: Commotio cordis — a blunt, non‑penetrating chest impact causing ventricular fibrillation without structural injury.

3. According to the 2024 AHA pre‑participation screening guideline, which of the following is mandatory for all competitive athletes aged 14 years and older?
   Answer: A 12‑lead resting ECG — it is required in addition to history and physical examination.

More in Forensic Medicine

AI-assisted study material for exam revision. Always confirm with standard textbooks and current guidelines; not medical advice.